Showing 61 - 80 results of 416 for search '"Cleveland"', query time: 0.03s Refine Results
  1. 61
  2. 62
  3. 63
  4. 64
  5. 65
  6. 66

    Pembrolizumab for the Treatment of Locally Advanced Cutaneous Squamous Cell Carcinoma: Patient Selection and Special Considerations by Stewart M, Geiger JL

    Published 2025-02-01
    “…Matthew Stewart,1 Jessica L Geiger2 1Department of Internal Medicine, Primary Care Institute, Cleveland Clinic Foundation, Cleveland, OH, USA; 2Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USACorrespondence: Matthew Stewart, Department of Internal Medicine, Primary Care Institute Cleveland Clinic Foundation, Cleveland, OH, USA, Email stewarm7@ccf.org Jessica L Geiger, Department of Hematology and Medical Oncology, Taussig Cancer Institute Cleveland Clinic Foundation, Cleveland, OH, USA, Email geigerj@ccf.orgAbstract: The treatment of locally advanced cutaneous squamous cell carcinoma (cSCC) has shifted with the advent of immune checkpoint inhibitors (ICIs). …”
    Get full text
    Article
  7. 67
  8. 68
  9. 69
  10. 70
  11. 71
  12. 72
  13. 73
  14. 74
  15. 75
  16. 76
  17. 77
  18. 78
  19. 79
  20. 80